FDA Will Face Reforms, Oversight In Republican Congress – Analysts
This article was originally published in The Rose Sheet
Executive Summary
Election gains will embolden Republicans to put FDA in Congress’ oversight “crosshairs,” as members of key Senate and House panels scrutinize how the agency is using its resources. Reforms also could come soon as part of the ongoing 21st Century Cures initiative.